• Aucun résultat trouvé

Biased signaling and L1 penalization

N/A
N/A
Protected

Academic year: 2021

Partager "Biased signaling and L1 penalization"

Copied!
67
0
0

Texte intégral

(1)

HAL Id: hal-02785169

https://hal.inrae.fr/hal-02785169

Submitted on 4 Jun 2020

HAL is a multi-disciplinary open access archive for the deposit and dissemination of sci- entific research documents, whether they are pub- lished or not. The documents may come from teaching and research institutions in France or abroad, or from public or private research centers.

L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d’enseignement et de recherche français ou étrangers, des laboratoires publics ou privés.

Biased signaling and L1 penalization

Romain Yvinec

To cite this version:

Romain Yvinec. Biased signaling and L1 penalization. ODE Modelling in Systems Biology, Sep 2017,

freibourg, Germany. �hal-02785169�

(2)

Biased signaling and L1 penalization

Towards a system biology definition of drugs selectivity

Romain Yvinec

BIOS, INRA Centre Val-de-Loire

(3)

What is biased signaling ?

Some examples

Bias calculus - standard method : operational model

Some extension to bias calculus

Biased signaling using dynamical model

(4)

Outline

What is biased signaling ?

Some examples

Bias calculus - standard method : operational model Some extension to bias calculus

Biased signaling using dynamical model

(5)

Functional selectivity, biased signaling

Exp. Biology 2005 (ASPET, San Diego)

Simmons, Mol. Interventions (2005)

Urban et al., J Pharmacol Exp Ther

(2007)

(6)

Functional selectivity, biased signaling

§

Ligand-specific activity in one receptor

Exp. Biology 2005 (ASPET, San Diego)

Simmons, Mol. Interventions (2005)

Urban et al., J Pharmacol Exp Ther

(2007)

(7)

Functional selectivity, biased signaling

§

Several potential pathways associate to a given receptor

Exp. Biology 2005 (ASPET, San Diego)

Simmons, Mol. Interventions (2005)

Urban et al., J Pharmacol Exp Ther

(2007)

(8)

Functional selectivity, biased signaling

§

Differential activation of certain pathways

Exp. Biology 2005 (ASPET, San Diego)

Simmons, Mol. Interventions (2005)

Urban et al., J Pharmacol Exp Ther

(2007)

(9)

Key concept in pharmacology

˛ Biased agonism is a key concept to be distinguish from

§

Partial or full agonist.

§

Antagonist, inverse agonist.

§

Affinity (K

d

), potency pEC

50

q, efficacy (E

max

).

(10)

Key concept in pharmacology

˛ Biased agonism is a key concept to be distinguish from

§

Partial or full agonist.

§

Antagonist, inverse agonist.

§

Affinity (K

d

), potency pEC

50

q, efficacy (E

max

).

˛ A bias might be context-dependent (cell type, physiological

state, etc.)

(11)

Key concept in pharmacology

˛ Biased agonism is a key concept to be distinguish from

§

Partial or full agonist.

§

Antagonist, inverse agonist.

§

Affinity (K

d

), potency pEC

50

q, efficacy (E

max

).

˛ A bias might be context-dependent (cell type, physiological state, etc.)

˛ Biased agonism is becoming a major tool in drug discovery.

ñ Candidate screening requires to accurately quantify bias.

(12)

Theoretical foundation

A receptor may adopt several spatial conformations, each of which has different activation pathway profiles.

§

Conformational selectivity = Ligand-specific modification of the energetic landscape, changing affinities and efficacies of signaling patways.

Kenakin, J Pharmacol Exp Ther (2011)

(13)

Theoretical foundation

A receptor may adopt several spatial conformations, each of which has different activation pathway profiles.

§

Conformational selectivity = Ligand-specific modification of the energetic landscape, changing affinities and efficacies of signaling patways.

§

Similar concept : modulating bias

Kenakin and Christopoulos, Nat. Rev. Drug Discov. (2013)

(14)

Summary so far

To speak about signaling bias, one necessarily needs two ligands and two responses, in a same cellular context.

ñ We always compare a ligand with respect to a reference one.

(15)

Outline

What is biased signaling ? Some examples

Bias calculus - standard method : operational model Some extension to bias calculus

Biased signaling using dynamical model

(16)

Serotonine receptor 5 ´ HT 2C

§

Quipazine is biaised towards PI

accumulation with respect to AA

production, compared to the reference agonist DOI.

§

LSD is not biased.

Berg et al., Mol.

Pharmacol. (1998)

(17)

Serotonine receptor 5 ´ HT 2C

§

Quipazine is biaised towards PI

accumulation with respect to AA

production, compared to the reference agonist DOI.

§

LSD is not biased.

§

Bias due to an E

max

difference.

Berg et al., Mol.

Pharmacol. (1998)

(18)

Serotonine receptor 5 ´ HT 2A

pRq ´ 2C ´ B ´ CB is biaised towards PI accumulation with respect to AA production, compared to the reference agonist DOB.

Urban et al., J Pharmacol Exp Ther (2007)

(19)

Serotonine receptor 5 ´ HT 2A

pRq ´ 2C ´ B ´ CB is biaised towards PI accumulation with respect to AA production, compared to the reference agonist DOB.

§

Bias due to an EC

50

difference.

Urban et al., J Pharmacol Exp Ther (2007)

(20)

Steroidogenesis modeulated by NAM

Some negative allosteric modulators (NAM) can biased Progesterone production with respect to Testosterone production, under stimulation of LH/CG receptor by hCG.

Ayoub et al., Mol. Cell.

Endocrinol (2016)

(21)

Steroidogenesis modeulated by NAM

Some negative allosteric modulators (NAM) can biased Progesterone production with respect to Testosterone production, under stimulation of LH/CG receptor by hCG.

§

Selective (biased) allosteric modulation

Ayoub et al., Mol. Cell.

Endocrinol (2016)

(22)

GPCR

Many GPCR’s are known to have biased ligands ( G / β-arrestin)

Kenakin, J Pharmacol Exp Ther (2011)

Kenakin, Chem Rev

(2017)

(23)

Outline

What is biased signaling ? Some examples

Bias calculus - standard method : operational model Some extension to bias calculus

Biased signaling using dynamical model

(24)

Operational model

Dose-response data are fitted with the function y “ E

tot

τ

n

rLs

n

prLs ` K

A

q

n

` τ

n

rLs

n

.

§

Response at equilibrium of a Michaelis-Menten type model.

§

K

A

“ Dissociation constant of the couple Ligand/Receptor

§

τ “ R

tot

{K

E

, Efficacy coefficient ( K

E

is dissociation constant of the ternary complex)

Black and Leff, Proc. R.

Soc. Lond. B (1983)

(25)

Operational model

Dose-response data are fitted with the function y “ E

tot

τ

n

rLs

n

prLs ` K

A

q

n

` τ

n

rLs

n

.

For n “ 1,

§

EC

50

τ`1KA

§

Efficacy y

8

{E

tot

τ`1τ

Black and Leff, Proc. R.

Soc. Lond. B (1983)

(26)

Operational model

Dose-response data are fitted with the function y “ E

tot

τ

n

rLs

n

prLs ` K

A

q

n

` τ

n

rLs

n

.

For n “ 1,

§

EC

50

τ`1KA

§

Efficacy y

8

{E

tot

τ`1τ

Then, we define

§

Transduction coefficient : R :“ log

ˆ τ K

A

˙

Black and Leff, Proc. R.

Soc. Lond. B (1983)

(27)

Bias definition With the operational model

Two ligands (j “ 1, 2) and two measured responses (i “ 1, 2) : Each dose-response data is fitted with the operational model :

y

ij

“ E

i

τ

ijni

rLs

ni

prLs ` Ka

ij

q

ni

` τ

ijni

rLs

ni

.

(28)

Bias definition With the operational model

Two ligands (j “ 1, 2) and two measured responses (i “ 1, 2) : Each dose-response data is fitted with the operational model :

y

ij

“ E

i

τ

ijni

rLs

ni

prLs ` Ka

ij

q

ni

` τ

ijni

rLs

ni

. For a given response i, we calculate

i

logpτ {K

a

q “ logpτ

i2

{Ka

i2

q ´ logpτ

i1

{Ka

i1

q.

(29)

Bias definition With the operational model

Two ligands (j “ 1, 2) and two measured responses (i “ 1, 2) : Each dose-response data is fitted with the operational model :

y

ij

“ E

i

τ

ijni

rLs

ni

prLs ` Ka

ij

q

ni

` τ

ijni

rLs

ni

. For a given response i, we calculate

i

logpτ {K

a

q “ logpτ

i2

{Ka

i2

q ´ logpτ

i1

{Ka

i1

q.

The Bias is then defined by

∆∆ logpτ {K

a

q “ ∆

2

logpτ {K

a

q ´ ∆

1

logpτ {K

a

q

(30)

Statistical consideration

Raue A., et al. Bioinformatics (2015)

(31)

Is bias calculation intuitive ? (simulated data)

§

A strong bias is usually ’apparent’ on dose-response curves or

bias plot

(32)

Is bias calculation intuitive ? (simulated data)

§

But there may be counter-intuitive situation...

(33)

Is bias calculation intuitive ? (simulated data)

§

But there may be counter-intuitive situation...

(34)

Is bias calculation intuitive ? (simulated data)

§

But there may be counter-intuitive situation...

(35)

§

... and those situations occur in real life !

(36)

Outline

What is biased signaling ? Some examples

Bias calculus - standard method : operational model Some extension to bias calculus

Biased signaling using dynamical model

(37)

Time-dependent bias

§

Bias value may change according to the response time after stimulation.

§

Kinetic explanation : Ligands with a slow binding kinetics may have changing bias value according to time.

Klein Herenbrink et al., Nat.

Commun (2016)

(38)

Other extensions

§

Dose-dependent bias Barak and Peterson et al., Biochem. (2012)

§

Extension of the operational model

Kenakin, Chem. Rev. (2017)

§

Method based on Intrinsic activities and rank ordering Onaran et al., Sci. Rep.

(2017)

(39)

Outline

What is biased signaling ? Some examples

Bias calculus - standard method : operational model Some extension to bias calculus

Biased signaling using dynamical model

(40)

Dynamic data (on FHSR in HEK cells)

Instead of focusing on dose-response curves, we deal with several doses kinetic experiments (here : induced BRET data)

0.0 0.1 0.2

0.3 dose 1 = -8.8 M β-arrestin

0.0 0.1 0.2

0.3 dose 2 = -8.1 M

0.0 0.1 0.2

0.3 dose 3 = -7.4 M

0 10 20 30 40 50

Time 0.0

0.1 0.2

0.3 dose 4 = -6.7 M

0.0 0.2 0.4

0.6 dose 1 = -11.3 M cAMP

0.0 0.2 0.4

0.6 dose 2 = -10.3 M

0.0 0.2 0.4

0.6 dose 3 = -9.3 M

0 10 20 30

Time 0.0

0.2 0.4

0.6 dose 4 = -8.3 M

Stimulation by FSH

(41)

Dynamic data (on FHSR in HEK cells)

Instead of focusing on dose-response curves, we deal with several doses kinetic experiments (here : induced BRET data)

0.0 0.1 0.2

0.3 dose 1 = -6.1 M β-arrestin

0.0 0.1 0.2

0.3 dose 2 = -5.4 M

0.0 0.1 0.2

0.3 dose 3 = -4.7 M

0 10 20 30 40 50

Time 0.0

0.1 0.2

0.3 dose 4 = -4.0 M

0.0 0.2 0.4

0.6 dose 1 = -8.0 M cAMP

0.0 0.2 0.4

0.6 dose 2 = -7.0 M

0.0 0.2 0.4

0.6 dose 3 = -6.0 M

0 10 20 30

Time 0.0

0.2 0.4

0.6 dose 4 = -5.0 M

Stimulation by C1

(42)

(”trick” to minimize variance...)

Original ”raw” data

0.0 0.1 0.2

0.3 dose 1 = -8.8 M β-arrestin

0.0 0.1 0.2

0.3 dose 2 = -8.1 M

0 10 20 30 40 50

Time 0.0

0.1 0.2

0.3 dose 3 = -7.4 M

0 10 20 30 40 50

Time 0.0

0.1 0.2

0.3 dose 4 = -6.7 M

(43)

(”trick” to minimize variance...)

”Adjusted” data

0.0 0.1 0.2

0.3 dose 1 = -8.8 M β-arrestin

0.0 0.1 0.2

0.3 dose 2 = -8.1 M

0 10 20 30 40 50

Time 0.0

0.1 0.2

0.3 dose 3 = -7.4 M

0 10 20 30 40 50

Time 0.0

0.1 0.2

0.3 dose 4 = -6.7 M

(44)

(”trick” to minimize variance...)

”Adjusted” data

0.0 0.1 0.2

0.3 dose 1 = -8.8 M β-arrestin

0.0 0.1 0.2

0.3 dose 2 = -8.1 M

0 10 20 30 40 50

Time 0.0

0.1 0.2

0.3 dose 3 = -7.4 M

0 10 20 30 40 50

Time 0.0

0.1 0.2

0.3 dose 4 = -6.7 M

+ adjusting the number of data points ...

(45)

Principle

I)We start with a sufficiently detailed chemical reaction network

(46)

Principle

I)We start with a sufficiently detailed chemical reaction network to accurately fit the data (one separate model for each Ligand)

0.0 0.1 0.2

0.3 β-arrestin, FSH

0.0 0.2 0.4 0.6

cAMP, FSH

0 10 20 30 40 50

Time 0.0

0.1 0.2

0.3 β-arrestin, C1

0 10 20 30

Time 0.0

0.2 0.4 0.6

cAMP, C1

(47)

Principle

II) We fit all data at once, using some common parameters (initial

concentration of molecules, measurement parameters...) and some

different ones (kinetic parameters...)

(48)

Principle

II) We fit all data at once, using some common parameters (initial concentration of molecules, measurement parameters...) and some different ones (kinetic parameters...)

0.0 0.1 0.2

0.3 β-arrestin, FSH

0.0 0.2 0.4 0.6

cAMP, FSH

0 10 20 30 40 50

Time 0.0

0.1 0.2

0.3 β-arrestin, C1

0 10 20 30

Time 0.0

0.2 0.4 0.6

cAMP, C1

(49)

Principle

III) We use L

1

-penalization to find the needed ligand specific parameters

Steiert, Timmer and Kreutz, Bioinformatics (2016)

(50)

Principle

III) We use L

1

-penalization to find the needed ligand specific parameters, keeping the fit ’as good as before’

0.0 0.1 0.2

0.3 β-arrestin, FSH

0.0 0.2 0.4 0.6

cAMP, FSH

0 10 20 30 40 50

Time 0.0

0.1 0.2

0.3 β-arrestin, C1

0 10 20 30

Time 0.0

0.2 0.4 0.6

cAMP, C1

Steiert, Timmer and Kreutz, Bioinformatics (2016)

(51)

Principle

IV) After re-optimization, the set of distinct (ligand-specific)

kinetic parameters gives us an accurate description of ligand

specificity.

(52)

Principle

V) Significant differences between parameters is assessed by PLE

4 2 0 2 4 6

0 σ

FSH param.

koff Kd kg kga k2 k2off

−4 −2 0 2 4 6

Parameter values 0

σ

koffKd C1 rel. param

kg kga k2 k2off

C1 is biased towards β -arr, compared to cAMP, in comparison to

FSH.

(53)

Practical problems...

0 200 400 600 800 1000

run index (sorted by likelihood) 10

2

10

4

10

6

likelihood

converged fits

initial objective function value

(54)

Practical problems...

-2 -1.995 -1.99 -1.985 -1.98 -1.975 -1.97 -1.965 -6.5502

-6.5501 -6.55 -6.5499 -6.5498

PL

10

4

95% (point-wise)

-2 -1.995 -1.99 -1.985 -1.98 -1.975 -1.97 -1.965 log (relto_239_kg)

-2 0 2 4

change of other parameters

k1

kgoff

Gtot

kg

kga

(55)

With a ”simpler” model

Kinetic model without G-protein

(56)

With a ”simpler” model

We obtain a slightly worse fit

0.0 0.1 0.2

0.3 β-arrestin, FSH

0.0 0.2 0.4 0.6

cAMP, FSH

0 10 20 30 40 50

Time 0.0

0.1 0.2

0.3 β-arrestin, C1

0 10 20 30

Time 0.0

0.2 0.4 0.6

cAMP, C1

(57)

With a ”simpler” model

But consistent results

(58)

With a ”simpler” model

And ”better” parameter identifiability

3 2 1 0 1 2 3 4

0 σ

FSH param.

k1 k2 koff Kd k1off k2off

−2 −1 0 1 2 3 4 5

Parameter values 0

σ

k1k2 C1 rel. param

koff Kd k1off k2off

C1 is biased towards β -arr, compared to cAMP, in comparison to

FSH.

(59)

With a ”simpler” model

0 100 200 300 400 500

run index (sorted by likelihood) 10

0

10

2

10

4

10

6

likelihood

converged fits

initial objective function value

(60)

Comparison with dose-response (on FHSR in HEK cells)

We systematically calculate bias value using standard method (operational model on dose-response curves :)

Bias=2.3 : C1 is biased towards β-arr, compared to cAMP, in

comparison to FSH.

(61)

Comparison with dose-response (on FHSR in HEK cells)

We systematically calculate bias value using standard method (operational model on dose-response curves :)

Bias=2.64 : C1 is biased towards β-arr, compared to cAMP, in

comparison to FSH.

(62)

Comparison with dose-response (on FHSR in HEK cells)

We systematically calculate bias value using standard method Different times gives (slightly) different bias values

C1 is biased towards β -arr, compared to cAMP, in comparison to

FSH.

(63)

Comparison with dose-response (on FHSR in HEK cells)

We systematically calculate bias value using standard method

Uncertainty can be large according to the time of measurement

(64)

Thanks for your attention !

§

Notion of signaling bias to quantify differential activation of several pathways by a Ligand at a given receptor.

§

Standard quantification has several drawbacks (no time, limited to sigmoid scenario,..).

§

We gave a kinetic interpretation of Ligand biased, which rely

on dynamic (ODE) modeling and parameter estimation with

L

1

penalization.

(65)

Thanks for your attention !

§

Notion of signaling bias to quantify differential activation of several pathways by a Ligand at a given receptor.

§

Standard quantification has several drawbacks (no time, limited to sigmoid scenario,..).

§

We gave a kinetic interpretation of Ligand biased, which rely on dynamic (ODE) modeling and parameter estimation with L

1

penalization.

§

Any other ideas how to define bias ?

§

How to deal with ”fuzzy/noisy” PLE ?

§

How to deal with non uniqueness of the penalized solution ?

§

How to perform a model reduction that would lead to both a

satisfactory fit and identifiable parameters ?

(66)

0 100 200 300 400 500 run index (sorted by likelihood)

10

0

10

2

10

4

likelihood

converged fits

initial objective function value

(67)

-0.5 -0.4 log10(k1) -6.1334

-6.1332 -6.133

2 PL

104 parameter #5 95% (point-wise)

-1.4 -1.3 -1.2 log10(k1off) parameter #6

-2.8 -2.7 log10(k2) parameter #7

6.5 7 7.5

log10(kd) parameter #8

0.5 1 1.5

log10(koff) -6.1334

-6.1332 -6.133

2 PL

104 parameter #9

-0.4 -0.3 -0.2 log10(krep) parameter #10

-0.06 -0.04 log10(relto_239_k1)

parameter #17

0.1 0.14 0.18 log10(relto_239_k1off)

parameter #18

0.8 0.9 1

log10(relto_239_k2) -6.1334

-6.1332 -6.133

2 PL

104 parameter #19

0.1 0.2 0.3

log10(relto_239_k2off) parameter #20

3.85 3.9

log10(relto_239_kd) parameter #21

0 5 10

log10(relto_239_koff) parameter #22

Références

Documents relatifs

Using population transcriptomics data, we analyzed the relationship between codon usage, gene expression, allele frequency distribution, and recombination rate in 30 nonmodel species

The plasma potential saturates at 15 V when the endplates are biased negatively com- pared to the grounded RFEA. This is because V ep is no longer the most positive potential in

Global all-sky SDSR and cloud cover averaged over the years 1961–1966 (baseline values) as observed (GEBA for radiation, CRU for cloud cover) and as simulated in the ensemble mean

sur bout de gomme atelier 2 chez Dixmois éevaluation tracés à la règle chez Maliluno atelier 3 chez Récréatisse atelier 1, je garde les suivants pour d'autres

Regulation of corticotropin-releasing hormone receptor type 1alpha signaling: structural determinants for G protein-coupled receptor kinase-mediated phosphorylation and

Keywords: GPCR, reproduction, follicle-stimulating hormone, β-arrestin, G protein, signaling, bias,

We systematically calculate bias value using standard method (operational model on dose-response curves :). Bias=2.3 : C3 is biased towards β-arr, compared to cAMP, in comparison

‚ We gave a fully kinetic and mechanistic description of Ligand biased, which rely on kinetic data and dynamic (ODE) modeling, with (advanced) statistical parameter estimation and L